ERBB2 and neoplasm: Six tumours with discordant results obtained by FISH and SISH were analysed by real-time quantitative PCR with the LightMix kit HER-2/neu (Roche Diagnostics), in order to classify them as amplified or non-amplified for HER2 (Table 3).